50 likes | 61 Views
Cancer Diagnostics Market size was valued at USD 160.5 billion in 2021 and is poised to grow from USD 171.5 billion in 2022 to USD 276.8 billion by 2030, growing at a CAGR of 6.89% in the forecast period (2023-2030).
E N D
Global Cancer Diagnostics Market Size, Share, Growth Analysis, By Test By Technology By Application By End User By Product - Industry Forecast 2023-2030 Cancer Diagnostics Market size was valued at USD 160.5 billion in 2021 and is poised to grow from USD 171.5 billion in 2022 to USD 276.8 billion by 2030, growing at a CAGR of 6.89% in the forecast period (2023-2030). Globally, more than 10 million people die of various types of cancers. Cancer is a major cause of death worldwide, and it's becoming more common. According to the World Health Organization, cancer will kill more people in 2030 than any other disease. However, 50% disease burden can be reduced by 2050 if early cancer diagnosis is performed. There are many different types of cancer, and each one has its own risks and symptoms. Some cancers are more common in some groups of people than others, and some are more deadly. Cancer is a complex disease, and there isn't always a single cause. However, the rise in prevalence of cancers in the recent years is majorly attributed to lifestyle choices, environmental exposures, and genetics. Cancer
can also be caused by abnormalities in the genes that control the growth and development of cells. There is no one cure for cancer, but early diagnosis and timely treatments can help manage the disease and extend people's lives. Global Cancer Diagnostics Market Segmental Analysis
Global cancer diagnostics market is segmented by test, technology, application, end user and region. Based on the test, the Cancer Diagnostics Market is segmented into instrument-based tests, laboratory tests, and liquid biopsies. Based on the application, the Cancer Diagnostics Market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach, liver, esophagus, thyroid, pancreatic cancer, leukemia, and others. Based on the technology, the Cancer Diagnostics Market is bifurcated into platform- based and instrument-based. By test, the market is segmented into Hospitals, Diagnostic Laboratories, Others. Based on product, the Cancer Diagnostics Market is segmented InstrumentsBased on Region, Cancer Diagnostics Market is categorized into North America, Europe, Asia- Pacific, Latin America, and MEA. into Consumables and View https://www.skyquestt.com/report/cancer-diagnostics- market more Cancer Diagnostics Market Top Player's Company Profiles
•Abbott Laboratories •Agilent Technologies •Becton, Dickinson and Company (BD) •bioMérieux SA •Danaher Corporation •F. Hoffmann-La Roche Ltd. •GE Healthcare •Hologic, Inc. •Illumina, Inc. •Koninklijke Philips N.V. •Merck KGaA •Myriad Genetics, Inc. •QIAGEN N.V. •Quest Diagnostics •Siemens Healthineers AG •Sysmex Corporation •Thermo Fisher Scientific Inc. •Toshiba Corporation •Varian Medical Systems, Inc. •Zimmer Biomet Holdings, Inc. About Us:
SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally. Address: 1 Apache Way, Westford, Massachusetts 01886 Phone: USA (+1) 617-230-0741 Email: sales@skyquestt.com LinkedIn Facebook Twitter